Logo image
Prognostic Impact of Comorbidities on Outcomes of Patients (pts) with Relapsed or Refractory Large B-Cell Lymphoma (r/r LBCL) Treated with Chimeric Antigen Receptor T-Cell Therapy (CART)
Abstract   Open access   Peer reviewed

Prognostic Impact of Comorbidities on Outcomes of Patients (pts) with Relapsed or Refractory Large B-Cell Lymphoma (r/r LBCL) Treated with Chimeric Antigen Receptor T-Cell Therapy (CART)

Uri Greenbaum, Hamza Hashmi, Mahmoud Elsawy, Soyoung Kim, Amy Moskop, Farrukh T. Awan, Umar Farooq, Siddhartha Ganguly, Peiman Hematti, Michael D. Jain, …
Blood, Vol.140(Supplement 1), pp.4636-4638
11/15/2022
DOI: 10.1182/blood-2022-169452
url
https://doi.org/10.1182/blood-2022-169452View
Published (Version of record) Open Access

Details

Logo image